Chrissy Metz Shares Progress Update on Weight Loss Journey With GLP-1 Medication

Actress Chrissy Metz has offered an update on her weight loss journey, telling fans she is "making progress" after publicly disclosing that she has begun treatment with a GLP-1 medication. The announcement has drawn renewed attention to the growing number of public figures turning to prescription drugs originally developed for type 2 diabetes to support weight management.

What Metz Has Said

Metz, best known for her role on the television series "This Is Us," revealed that she had started a GLP-1 medication as part of her broader health plan. In a recent update, she emphasised steady results rather than rapid transformation, framing her experience as gradual and ongoing. Her comments reflect a wider trend of celebrities discussing the medications openly, even as questions remain about long-term use, cost, and access.

Why GLP-1 Drugs Are in the Spotlight

GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar, and several have been approved for chronic weight management in adults with obesity or related conditions. Their rise has been accompanied by growing interest in how newer treatments fit alongside traditional approaches such as diet and fasting protocols.

Key Takeaways

• Metz confirmed she is using a GLP-1 medication and described her progress as steady.
• GLP-1 drugs were initially developed for type 2 diabetes and are now widely used for weight management.
• Her openness adds to a broader public conversation about medical support for weight loss and the choices individuals make.

As more people consider prescription options, resources such as guides on protein intake for muscle hypertrophy and initiatives promoting nutritional literacy highlight the importance of pairing any treatment with informed lifestyle habits. Metz has not yet disclosed the specific medication she is taking or the duration of her treatment plan.